glp 1 drugs kidney disease GLP-1 Receptor Agonists and Diabetic Disease: A Call of Attention to Nephrologists GLP-1 Medications & Their Potential
Description
Ongoing monitoring and follow-up should include regular re-assessment of dietary intake and hydration, for example, using food logs and/or food photos, and re-assessment of nutrient levels, using clinically accepted methodologies, during therapy to identify and promptly address emerging deficiencies
Today, there is still a large number of GLP-1R agonists entering clinical trials, which will lead to a big explosion in the future, so let's wait and see together
Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, et al
Glucagon Glucagon raises blood sugar levels
GLP-1 is also believed to participate in weight loss after bariatric surgery which brings food more rapidly into the distal small intestine
Evidently, the differences amongst the results point towards in-class heterogeneity
